{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:09:48Z","timestamp":1773385788051,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T00:00:00Z","timestamp":1142380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmo"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00417-005-0191-4","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T17:03:16Z","timestamp":1142355796000},"page":"1246-1249","source":"Crossref","is-referenced-by-count":27,"title":["Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case\u2013control study in a Chinese population"],"prefix":"10.1007","volume":"244","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2013Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai\u2013Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,15]]},"reference":[{"key":"191_CR1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/112067210201200608","volume":"12","author":"AM Abu El-Asrar","year":"2002","unstructured":"Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS (2002) Hyperhomocysteinemia and retinal vascular occlusion disease. Eur J Ophthalmol 12:495\u2013500","journal-title":"Eur J Ophthalmol"},{"key":"191_CR2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bjo.85.11.1313","volume":"85","author":"S Boyd","year":"2001","unstructured":"Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin PG (2001) Plasma homocysteine, methylenetetrahydrofolate reeducates C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 85:1313\u20131315","journal-title":"Br J Ophthalmol"},{"key":"191_CR3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.33588\/rn.3705.2002594","volume":"37","author":"MM Cabezas-Leon","year":"2003","unstructured":"Cabezas-Leon MM, Garcia-Montero MR, Morente-Matas P(2003) Hyperhomocysteinemia as a risk factor for central retinal vein thrombosis in a young patient. Rev Neurol 37:441\u2013443","journal-title":"Rev Neurol"},{"key":"191_CR4","first-page":"262","volume":"59","author":"R Franchis De","year":"1996","unstructured":"De Franchis R, Mancini FP, D\u2019Angelo A, Sebastio G, Fermo I, de Stefano V, Margaglione M, Mazzola G, di Minno G, Andria G (1996) Elevated total plasma homocysteine and 677C3T mutation of the 5, 10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59:262\u2013264","journal-title":"Am J Hum Genet"},{"key":"191_CR5","first-page":"142","volume":"56","author":"AMT Engbersen","year":"1995","unstructured":"Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HK (1995) Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause for mild hyperhomocysteinemia. Am J Hum Genet 56:142\u2013150","journal-title":"Am J Hum Genet"},{"key":"191_CR6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775\u20131781","journal-title":"JAMA"},{"key":"191_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9150(99)00321-4","volume":"149","author":"AE Hak","year":"2000","unstructured":"Hak AE, Polderman KH, Westendorp I, Jakobs C, Hofman A, Witteman JCM, Stehouwer CD (2000) Increased plasma homocysteine after menopause. Atherosclerosis 149:163\u2013168","journal-title":"Atherosclerosis"},{"key":"191_CR8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00417-001-0421-3","volume":"240","author":"SS Hayreh","year":"2002","unstructured":"Hayreh SS, Zimmerman MB, Podhajsky P (2002) Hematological abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:180\u2013196","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"191_CR9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000045423","volume":"83","author":"BF Henning","year":"1999","unstructured":"Henning BF, Riezler RR, Tepel M, Langer K, Raidt H, Graefe U, Zidek W (1999) Evidence of altered homocysteine metabolism in chronic renal failure. Nephron 83:314\u2013322","journal-title":"Nephron"},{"key":"191_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.18.1.133","volume":"18","author":"EK Hoogeveen","year":"1998","unstructured":"Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJC, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD (1998) Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin dependent diabetes mellitus: a population based study. Arterioscler Thromb Vasc Biol 18:133\u2013138","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"191_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-0420.2000.078003340.x","volume":"78","author":"J Larsson","year":"2000","unstructured":"Larsson J, Hultberg B, Hillarp A (2000) Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand 78:340\u2013343","journal-title":"Acta Ophthalmol Scand"},{"key":"191_CR12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.ATV.17.6.1157","volume":"17","author":"MR Malinow","year":"1997","unstructured":"Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR (1997) The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 17:1157\u20131162","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"191_CR13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.87.4.1107","volume":"87","author":"MR Malinow","year":"1993","unstructured":"Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G (1993) Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 87:1107\u20131113","journal-title":"Circulation"},{"key":"191_CR14","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.158.19.2101","volume":"158","author":"JG Ray","year":"1998","unstructured":"Ray JG (1998) Meta\u2013analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158:2101\u20132106","journal-title":"Arch Intern Med"},{"key":"191_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","volume":"49","author":"H Refsum","year":"1998","unstructured":"Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med 49:31\u201362","journal-title":"Annu Rev Med"},{"key":"191_CR16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0161-6420(02)01044-8","volume":"109","author":"M Weger","year":"2002","unstructured":"Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Quehenberge F, Semmelrock J, Haas A (2002) Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology 109:1105\u20131109","journal-title":"Ophthalmology"},{"key":"191_CR17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000076144","volume":"218","author":"C Yildirim","year":"2004","unstructured":"Yildirim C, Yaylali V, Tatlipinar S, Kaptanoglu B, Akpinar S (2004) Hyperhomocysteinemia: a risk factor for retinal vein occlusion. Ophthalmologica 218:102\u2013106","journal-title":"Ophthalmologica"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-0191-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-005-0191-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-0191-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:43:21Z","timestamp":1736297001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-005-0191-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,15]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1007\/s00417-005-0191-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,15]]}}}